Journal of Biological Chemistry 2009-01-30

The cyclin-dependent kinase activator, Spy1A, is targeted for degradation by the ubiquitin ligase NEDD4.

Mohammad Al Sorkhy, Ryan Craig, Brenna Market, Ryan Ard, Lisa A Porter

Index: J. Bacteriol. 284 , 2617-27, (2009)

Full Text: HTML

Abstract

Spy1A is a cyclin-like protein required for progression through the G(1)/S phase of the cell cycle. Elevated Spy1A protein levels have been implicated in tumorigenesis and are attributed to overriding the DNA damage response and enhancing cell proliferation. Understanding how Spy1A is produced and degraded is essential in resolving how it contributes to normal and abnormal growth processes. Herein, we demonstrate that Spy1A is degraded in a cell cycle-dependent manner during mitosis via the ubiquitin-proteasome system. We have resolved the E3 ligase and essential phosphorylation sites mediating Spy1A degradation. Furthermore, we have determined that non-degradable forms of Spy1A do not trigger cell cycle arrest but, rather, contribute to uncontrolled cell growth. Further investigation into the regulation of Spy1A may reveal novel strategies for understanding the etiology and progression of specific growth disorders.


Related Compounds

Related Articles:

miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells.

2015-03-20

[Oncotarget 6(8) , 6014-28, (2015)]

Dominant negative effect of polyglutamine expansion perturbs normal function of ataxin-3 in neuronal cells.

2015-01-01

[Hum. Mol. Genet. 24(1) , 100-17, (2014)]

Hypoxia reduces MAX expression in endothelial cells by unproductive splicing.

2014-12-20

[FEBS Lett. 588(24) , 4784-90, (2014)]

Beclin 1 restrains tumorigenesis through Mcl-1 destabilization in an autophagy-independent reciprocal manner.

2014-01-01

[Nat. Commun. 5 , 5637, (2014)]

Proteasome functioning in breast cancer: connection with clinical-pathological factors.

2014-01-01

[PLoS ONE 9(10) , e109933, (2014)]

More Articles...